Valuation: Bavarian Nordic A/S

Market Cap 14.04B 2.15B 1.88B 1.73B 1.6B 3.04B 205B 3.09B 20.69B 8.13B 101B 8.06B 7.89B 347B P/E 2026 *
21.3x
P/E 2027 * 20.4x
Enterprise Value 10.08B 1.54B 1.35B 1.24B 1.15B 2.18B 147B 2.22B 14.87B 5.84B 72.46B 5.79B 5.66B 249B EV / Sales 2026 *
1.81x
EV / Sales 2027 * 1.6x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day-0.92%
1 week-3.67%
Current month+0.44%
1 month+0.66%
3 months-7.04%
6 months-7.60%
Current year-3.85%
1 week 181.3
Extreme 181.3
192.4
1 month 171.3
Extreme 171.3
192.4
Current year 171.3
Extreme 171.3
203.4
1 year 171.3
Extreme 171.3
244.8
3 years 123.3
Extreme 123.3
300
5 years 115.2
Extreme 115.2
411
10 years 103.2
Extreme 103.2
444
Manager TitleAgeSince
Chief Executive Officer 59 2014-05-27
Director of Finance/CFO 61 2018-10-31
Chief Tech/Sci/R&D Officer - 2019-10-31
Director TitleAgeSince
Director/Board Member 63 2016-04-19
Chairman 63 2025-11-12
Director/Board Member 46 2020-12-31
Date Insider Type Main position Quantity % Market Cap.
25-05-08Fiscal year

Chairman

983 0.0012%
25-05-08Fiscal year

Director

983 0.0012%
25-05-08Fiscal year

Director

983 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-3.67%-0.14%+0.55% 2.15B
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -0.90%-3.29%+21.95%+50.02% 357.61B
Weighted average by Cap. -0.56%-2.96%+35.26%+81.22%

Financials

2026 *2027 *
Net sales 5.56B 850M 743M 686M 633M 1.2B 81.06B 1.22B 8.19B 3.22B 39.93B 3.19B 3.12B 137B 5.56B 851M 744M 686M 634M 1.2B 81.15B 1.22B 8.2B 3.22B 39.98B 3.19B 3.13B 137B
Net income 672M 103M 89.9M 82.92M 76.59M 145M 9.8B 148M 991M 389M 4.83B 386M 378M 16.6B 699M 107M 93.56M 86.29M 79.7M 151M 10.2B 154M 1.03B 405M 5.03B 402M 393M 17.28B
Net Debt -3.95B -605M -529M -488M -451M -855M -57.67B -869M -5.83B -2.29B -28.41B -2.27B -2.22B -97.66B -5.14B -786M -687M -634M -585M -1.11B -74.92B -1.13B -7.57B -2.97B -36.91B -2.95B -2.89B -127B
Logo Bavarian Nordic A/S
Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases. Net sales by revenue source are divided between sales of products (97,2%) and services (2,8%). Net sales are distributed geographically as follows: the United States (43.2%), Germany (18.6%), France (11.6%), Canada (3.6%), THE United Kingdom (3.4%), Finland (2.9%), Singapore (2.2%), Switzerland (1.7%), Australia (1.3%), Saudi Arabia (1.2%), Spain (0.6%), and others (9.7%).
Employees
1,861
Date Price Change Volume
26-07-10 DKK 183.50 -0.92% 257,948
26-07-09 DKK 185.20 -1.33% 412,942
26-07-08 DKK 187.70 -0.37% 178,458
26-07-07 DKK 188.40 -0.95% 252,860
26-07-06 DKK 190.20 -0.16% 208,217
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
183.50DKK
Average target price
267.50DKK
Spread / Average Target
+45.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAVA Stock